Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities HALO - Halozyme Therapeutics, Inc.
-408 M
LAST VALUE
-149.79%
2 YEAR CAGR
-44.93%
5 YEAR CAGR
-32.97%
10 YEAR CAGR